(Q54638432)

English

Ras-related protein 1 and the insulin-like growth factor type I receptor are associated with risk of progression in patients diagnosed with carcinoma in situ.

scientific article published on 26 October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/20976540

Ras-related protein 1 and the insulin-like growth factor type I receptor are associated with risk of progression in patients diagnosed with carcinoma in situ. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/20976540

Douglas L. Fraker

6

object named as

Douglas L Fraker

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/20976540

author name string

Dana K Furstenau

1

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/20976540

Nandita Mitra

2

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/20976540

Fei Wan

3

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/20976540

Robert Lewis

4

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/20976540

Michael D Feldman

5

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/20976540

Marina A Guvakova

7

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/20976540

language of work or name

0 references

publication date

26 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/20976540

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/20976540

129

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/20976540

2

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/20976540

361-372

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/20976540

https://scigraph.springernature.com/pub.10.1007/s10549-010-1227-y

0 references

National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Ductal carcinoma in situ: state of the science and roadmap to advance the field

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Heterogeneity of the motility responses in malignant tumor cells: a biological basis for the diversity and homing of metastatic cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Signal transduction by beta1 integrin receptors in human chondrocytes in vitro: collaboration with the insulin-like growth factor-I receptor

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Association of insulin receptor substrate-1 with integrins

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Inhibition of the type I insulin-like growth factor receptor expression and signaling: novel strategies for antimetastatic therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Analysis of gene expression involved in brain metastasis from breast cancer using cDNA microarray

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Inflammatory breast cancer: relationship between growth factor signaling and motility in aggressive cancers

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

The type 1 insulin-like growth factor receptor pathway

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Regulation of the RAP1/RAF-1/extracellularly regulated kinase-1/2 cascade and prolactin release by the phosphoinositide 3-kinase/AKT pathway in pituitary cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Identification and biochemical characterization of Rap2C, a new member of the Rap family of small GTP-binding proteins

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Rap1 signalling: adhering to new models

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Biology of the Rap proteins, members of the ras superfamily of GTP-binding proteins

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Linking Rap to cell adhesion

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Cellular functions of the Rap1 GTP-binding protein: a pattern emerges

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Rap1 GTPase: Functions, Regulation, and Malignancy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Rap1, a mercenary among the Ras-like GTPases

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Alterations in the rap1 signaling pathway are common in human gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Loss of Rap1GAP in papillary thyroid cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

DOCK4, a GTPase activator, is disrupted during tumorigenesis

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Amplification, up-regulation and over-expression of C3G (CRK SH3 domain-binding guanine nucleotide-releasing factor) in non-small cell lung cancers

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Regulation of lymphocyte adhesion and migration by the small GTPase Rap1 and its effector molecule, RAPL.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Local activation of Rap1 contributes to directional vascular endothelial cell migration accompanied by extension of microtubules on which RAPL, a Rap1-associating molecule, localizes

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Sequential activation of Rap1 and Rac1 small G proteins by PDGF locally at leading edges of NIH3T3 cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Rap1 integrates tissue polarity, lumen formation, and tumorigenic potential in human breast epithelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Insulin-like growth factors control cell migration in health and disease

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Targeting the insulin-like growth factor receptor-1R pathway for cancer therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Molecular alterations in ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

The molecular journey from ductal carcinoma in situ to invasive breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

The role of endocrine insulin-like growth factor-I and insulin in breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Type I insulin-like growth factor receptor as a therapeutic target in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: lessons from the first clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1227-Y

21 January 2018

Identifiers

10.1007/S10549-010-1227-Y

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/20976540

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/20976540

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54638432&oldid=1997836178"